BIO.News Newsletter

Today, we’re giving the floor to BIO’s State Government Affairs team to review major state legislation enacted in 2021. We’re running slightly longer today (1,100 words, 6 minutes) but we hope this gives you a good overview of state legislature activity so far this year.

It was a long night on Capitol Hill. Here’s a quick recap of what happened in the Senate and where to find more information on the infrastructure and budget bills, plus a few good reads you might have missed. (551 words, 2 minutes, 45 seconds)

Today, BIO’s joining government and business leaders in calling for U.S. leadership on global vaccination. We also take a closer look at the new UN report on climate change—and how biotech offers solutions to lessen the impact. (681 words, 3 minutes, 24 seconds)

It’s a new week—and the SEC approved an important Nasdaq proposal that will improve diversity and inclusion in public companies. We tell you how you can get more details, plus look at why opposition to GMOs has been so misplaced. (655 words, 3 minutes, 16 seconds)

Closing the week with an update on COVID-19 and COVAX in Asia as the Tokyo Olympics wind down—and a must-read warning about why America must embrace the biotech sector. (751 words, 3 minutes, 45 seconds)

Today, we look at the alarming number of anti-vaccine laws popping up in states across the country, as well as the latest on what USTR is doing about biotech in Mexico. (784 words, 3 minutes, 55 seconds)

The Philippines is the first country to approve Golden Rice for commercial production—we have the details. Plus, the American Heart Association (AHA) explains why diversity matters in genomic research and what we can do to improve it. (731 words, 3 minutes, 39 seconds)

Starting Tuesday with a look at what BIO says about Europe’s proposed health data initiative—and why we must prepare for a “plant pandemic,” too. (675 words, 3 minutes, 22 seconds)

It’s August—and National Immunization Awareness Month. We begin the new month with a look at why we need to return to routine vaccines, as well as promising news from a BIO member creating more sustainable food and jobs. (565 words, 2 minutes, 49 seconds)

Closing the week with what BIO’s Dr. Cartier Esham said yesterday about investment in neurodegenerative disease—and BIO’s recommendations for advancing clinical development in this area. Also, details on USDA's new report on the economic benefits of the bioeconomy and a new I am BIO video. (756 words, 3 minutes 46 seconds)